Arnold Schwarzenegger is raising awareness about prioritizing joint health and mobility and is helping fans fuel their ...

Among Zimmer Biomet's knee solutions featured at the AAOS 2025, the newly cleared Persona Revision SoluTion Femur is expected to draw attention.

Proficio Capital Partners LLC bought a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) during ...

Zimmer Biomet CEO Ivan Tornos said he anticipates ASCs to be a major support for growing orthopedic case volumes during the Barclays 27th Annual Global Healthcare Conference. “That is a huge tailwind ...

Zimmer Biomet ZBH continues to gain from procedure strength, strong execution and solid momentum in innovation. Yet the stock ...

Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...

Stryker continues to enjoy extensive financial flexibility, even as it has issued more debt to finance the purchase of some larger acquisitions. At the end of 2024, the firm's net debt/EBITDA was 1.9 ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting its diverse portfolio of orthopedic and musculoskeletal innovations at the ...

A history of aerobiology would normally be a book that would have little interest beyond the science community. But in ...

A Revision Knee Implant Alternative for Patients with Metal Sensitivities WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ...

Zimmer Biomet Holdings, Inc. , a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTiontm Femur, a revision knee ...

The global Orthopedic Devices Market , valued at US$49.63 billion in 2023, is forecasted to grow at a robust CAGR of 14.5%, reaching US$51.61 ...